|
John Yonkin serves as President, US Point of Care for our Professional Diagnostics strategic business unit, a role which he assumed in April 2006. He also leads our Nutritionals strategic business unit, as he has done since April 2005. Prior to that Mr. Yonkin served as Vice President of US Sales & Marketing from November 2001. Mr. Yonkin served as Vice President of US Sales of our predecessor company, Inverness Medical Technology, from October 1998 through January 2000 and its General Manager from January 2000 through November 2001, when that company was acquired by Johnson & Johnson. He also served as Manager of Product Development for Inverness Medical Technology from October 1997 until October 1998. From January 1995 to September 1997, Mr. Yonkin was Director of National Accounts for Genzyme Genetics, a subsidiary of Genzyme, Inc., a leader in genetic testing services for hospitals, physicians and managed healthcare companies. | 